5 |
<td><font color="#993333"><b><img src="fc/point_2.gif" width="35" height="12">DIURETICS</b></font></td> |
<td><font color="#993333"><b><img src="fc/point_2.gif" width="35" height="12">DIURETICS</b></font></td> |
6 |
</tr> |
</tr> |
7 |
</table> |
</table> |
8 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
9 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
10 |
<tr> |
<tr> |
11 |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
23 |
; submitted in US only </font></td> |
; submitted in US only </font></td> |
24 |
</tr> |
</tr> |
25 |
</table> |
</table> |
26 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
27 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
28 |
<tr> |
<tr> |
29 |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
41 |
; submitted in 6 countries </font></td> |
; submitted in 6 countries </font></td> |
42 |
</tr> |
</tr> |
43 |
</table> |
</table> |
44 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
45 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
46 |
<tr> |
<tr> |
47 |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
59 |
; submitted in 26 countries </font></td> |
; submitted in 26 countries </font></td> |
60 |
</tr> |
</tr> |
61 |
</table> |
</table> |
62 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
63 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
64 |
<tr bgcolor="#ECF5FF"> |
<tr bgcolor="#ECF5FF"> |
65 |
<td><font color="#993333"><b><img src="fc/point_2.gif" width="35" height="12">SULFONAMIDES</b></font></td> |
<td><font color="#993333"><b><img src="fc/point_2.gif" width="35" height="12">SULFONAMIDES</b></font></td> |
66 |
</tr> |
</tr> |
67 |
</table> |
</table> |
68 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
69 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
70 |
<tr> |
<tr> |
71 |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
83 |
; submitted in 6 countries </font></td> |
; submitted in 6 countries </font></td> |
84 |
</tr> |
</tr> |
85 |
</table> |
</table> |
86 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
87 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
88 |
<tr> |
<tr> |
89 |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
101 |
; submitted in 3 countries </font></td> |
; submitted in 3 countries </font></td> |
102 |
</tr> |
</tr> |
103 |
</table> |
</table> |
104 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
105 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
106 |
<tr> |
<tr> |
107 |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
119 |
; submitted in 4 countries</font></td> |
; submitted in 4 countries</font></td> |
120 |
</tr> |
</tr> |
121 |
</table> |
</table> |
122 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
123 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
124 |
<tr bgcolor="#ECF5FF"> |
<tr bgcolor="#ECF5FF"> |
125 |
<td><font color="#993333"><b><img src="fc/point_2.gif" width="35" height="12">ANTIBIOTICS</b></font></td> |
<td><font color="#993333"><b><img src="fc/point_2.gif" width="35" height="12">ANTIBIOTICS</b></font></td> |
126 |
</tr> |
</tr> |
127 |
</table> |
</table> |
128 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
129 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
130 |
<tr> |
<tr> |
131 |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
143 |
No.61-236 ; submitted in 17 countries</font></td> |
No.61-236 ; submitted in 17 countries</font></td> |
144 |
</tr> |
</tr> |
145 |
</table> |
</table> |
146 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
147 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
148 |
<tr> |
<tr> |
149 |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
161 |
No.61-235 ; submitted in 12 countries</font></td> |
No.61-235 ; submitted in 12 countries</font></td> |
162 |
</tr> |
</tr> |
163 |
</table> |
</table> |
164 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
165 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
166 |
<tr> |
<tr> |
167 |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
178 |
<td colspan="2"><font color="#000099">Packing: upon request</font></td> |
<td colspan="2"><font color="#000099">Packing: upon request</font></td> |
179 |
</tr> |
</tr> |
180 |
</table> |
</table> |
181 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
182 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
183 |
<tr bgcolor="#ECF5FF"> |
<tr bgcolor="#ECF5FF"> |
184 |
<td><font color="#993333"><b><img src="fc/point_2.gif" width="35" height="12">VARIOUS |
<td><font color="#993333"><b><img src="fc/point_2.gif" width="35" height="12">VARIOUS |
185 |
ACTIVE PHARMACEUTICAL INGREDIENTS </b></font></td> |
ACTIVE PHARMACEUTICAL INGREDIENTS </b></font></td> |
186 |
</tr> |
</tr> |
187 |
</table> |
</table> |
188 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
189 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
190 |
<tr> |
<tr> |
191 |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
203 |
; submitted in 20 countries </font></td> |
; submitted in 20 countries </font></td> |
204 |
</tr> |
</tr> |
205 |
</table> |
</table> |
206 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
207 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
208 |
<tr> |
<tr> |
209 |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
221 |
; submitted in 5 countries </font></td> |
; submitted in 5 countries </font></td> |
222 |
</tr> |
</tr> |
223 |
</table> |
</table> |
224 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
225 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
226 |
<tr> |
<tr> |
227 |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
240 |
; submitted in US only </font></td> |
; submitted in US only </font></td> |
241 |
</tr> |
</tr> |
242 |
</table> |
</table> |
243 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
244 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
245 |
<tr> |
<tr> |
246 |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
258 |
8551 ; submitted in US only</font></td> |
8551 ; submitted in US only</font></td> |
259 |
</tr> |
</tr> |
260 |
</table> |
</table> |
261 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
262 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
263 |
<tr bgcolor="#ECF5FF"> |
<tr bgcolor="#ECF5FF"> |
264 |
<td height="20"><font color="#993333"><b><img src="fc/point_2.gif" width="35" height="12">INTERMEDIATES</b></font></td> |
<td height="20"><font color="#993333"><b><img src="fc/point_2.gif" width="35" height="12">INTERMEDIATES</b></font></td> |
265 |
</tr> |
</tr> |
266 |
</table> |
</table> |
267 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
268 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
269 |
<tr> |
<tr> |
270 |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
276 |
<td width="285"><font color="#336699">25 kg drum </font></td> |
<td width="285"><font color="#336699">25 kg drum </font></td> |
277 |
</tr> |
</tr> |
278 |
</table> |
</table> |
279 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
280 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
281 |
<tr> |
<tr> |
282 |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
289 |
<td width="285"><font color="#336699">30 kg drum</font></td> |
<td width="285"><font color="#336699">30 kg drum</font></td> |
290 |
</tr> |
</tr> |
291 |
</table> |
</table> |
292 |
<img src="fc/images/blind.gif" width="8" height="10"> |
<img src="t/n.gif" width="8" height="10"> |
293 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
294 |
<tr> |
<tr> |
295 |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |
<td width="35"><img src="fc/point_2.gif" width="35" height="12"> </td> |